By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Horizon Discovery today said that it has inked technology access agreements with the National Cancer Institute and National Human Genome Research Institute, under which researchers at the two institutes will use Horizon's rAAV gene editing technology, called Genesis, to engineer human isogenic disease models.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.